Sinethemba Yakobi | Antimicrobial Resistance | Best Researcher Award

Posted on by ScienceFather

Mr. Sinethemba Yakobi | Antimicrobial Resistance | Best Researcher Award

Mr. Sinethemba Yakobi, University of KwaZulu Natal, South Africa

Sinethemba Hopewell Yakobi, a South African geneticist and medical technologist 🧬. With a PhD in Biochemistry and extensive experience in clinical research, Yakobi specializes in genetics and assay development, particularly in Medical Microbiology and Virology. He has a proven track record in laboratory management, research, and publication. His work focuses on antimicrobial resistance, particularly in Neisseria gonorrhoeae. With leadership roles in academic and clinical settings, Yakobi is known for his meticulous attention to detail and commitment to advancing medical knowledge. 🏥💡

Publication Profile:

Orcid

Education:

Sinethemba Hopewell Yakobi embarked on his academic journey at Lady Grey Arts Academy, where he completed his Grade 12 education in 2008. Driven by a passion for science, he pursued a National Diploma in Biomedical Technology at Cape Peninsula University of Technology in 2011, specializing in Clinical Pathology. Building on this foundation, he obtained a Bachelor of Technology in Biomedical Technology in 2012, majoring in Molecular Biology and Laboratory Management. His pursuit of knowledge led him to complete a Master of Technology in Biomedical Technology at Cape Peninsula University of Technology in 2016, focusing on Molecular Biology and Microbiology. Currently, Yakobi is on the brink of receiving his PhD in Biochemistry from the University of KwaZulu Natal, with a thesis submission in February 2024 and graduation anticipated in April 2024. His academic journey reflects a relentless dedication to advancing scientific understanding and contributing to the field of medicine. 🎓🔬

 

Research Experience:

Sinethemba Hopewell Yakobi’s research journey spans across esteemed institutions, showcasing his dedication to advancing medical science. At the University of KwaZulu Natal, Yakobi directed groundbreaking laboratory research on drug development for uncomplicated gonorrhoeae, aligning with FDA perspectives. 🧫 His tenure at the Department of Biochemistry delved into isolating antimicrobial bioactive components from Pleurotus ostreatus mushrooms, exploring their potential against drug-resistant pathogens. 🍄 Prior, at Cape Peninsula University of Technology, his investigation into antibiotic-resistant strains in wastewater underscored his commitment to understanding and combating microbial challenges. Yakobi’s research endeavors exemplify his pursuit of innovative solutions to pressing medical issues. 🌱

 

Research Focus:

Sinethemba Yakobi’s research primarily focuses on combating antimicrobial resistance, particularly in Neisseria gonorrhoeae. 🦠 His studies delve into understanding the mechanisms of resistance and developing novel therapeutic strategies against drug-resistant strains. Yakobi’s contributions range from identifying emerging multidrug-resistant isolates to screening antimicrobial properties of natural compounds against various pathogens. Through molecular docking studies and structure-activity relationship analyses, he aims to elucidate potential targets for drug development, as seen in his investigation of compounds against glyceraldehyde-3-phosphate dehydrogenase in azithromycin-resistant Neisseria gonorrhoeae. 🎯 His dedication to addressing pressing public health concerns underscores his commitment to advancing medical science.

Publication Top Notes:

Molecular Docking and Structure‐Activity Relationship Analysis of Target Compounds against Glyceraldehyde‐3‐Phosphate Dehydrogenase in Azithromycin‐Resistant Neisseria gonorrhoeae

The Influence of Organic Phenolic Compounds on the Proliferation and Kinetic Growth of Pathogenic Multi-Drug Resistant Neisseria Gonorrhoeae Strains

Screening of Antimicrobial Properties and Bioactive Compounds of Pleurotus Ostreatus Extracts against Staphylococcus Aureus, Escherichia coli, and Neisseria Gonorrhoeae

Identification of Emerging Multidrug-Resistant Neisseria gonorrhoeae Isolates against Five Major Antimicrobial Agent Options

Antimicrobial Resistance of Neisseria gonorrhoeae in Sub-Saharan Populations

Monocyte-mediated inflammation and cardiovascular risk factors in type 2 diabetes mellitus: A systematic review and meta-analysis of pre-clinical and clinical studies

Chika Anekwe | Preventive Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Chika Anekwe | Preventive Medicine | Best Researcher Award

Dr. Chika Anekwe, Massachusetts General Hospital,United States

Dr. Chika Anekwe is a distinguished physician and public health advocate with expertise in obesity medicine. 🩺 She holds an MD from the University of Connecticut and an MPH from Columbia University. Currently an Assistant Physician at Massachusetts General Hospital, she previously served at SUNY Stony Brook and Harvard Medical School. Dr. Anekwe’s research focuses on innovative obesity treatments, earning her recognition such as the Biodiversity Fellows Leadership Development Program. She’s also the founder of the New England Obesity Society and contributes as a medical reviewer for Very Well Health. 🏅📚

 

Publication Profile:

Google Scholar

Education:

Dr. Chika Anekwe pursued a diverse academic journey, earning an AB in Molecular Biology from Princeton University in 2006, followed by an MD in Medicine from the University of Connecticut in 2011. 🎓 Her thirst for knowledge led her to attain a Master of Public Health (MPH) degree from Columbia University in 2014, rounding out her expertise in healthcare and public health. 🏥 Throughout her educational endeavors, Dr. Anekwe demonstrated a commitment to understanding the intricate intersections of biology, medicine, and public health, laying the foundation for her impactful career in the healthcare sector.

Honors and Prizes:

Dr. Chika Anekwe’s dedication and achievements have garnered her prestigious honors and prizes throughout her career. 🏆 As a Jackie Robinson Foundation Scholar from 2002 to 2006, she exemplified academic excellence. She continued to excel as an Extra Innings Fellow from 2007 to 2011, supported by the Jackie Robinson Foundation. Additionally, she was recognized as a Sylvia Parkinson Scholar in 2010 by The Hartford Foundation for Public Giving. Her commitment to leadership and innovation was further acknowledged through her participation in the Biodiversity Fellows Leadership Development Program in 2018-2019. Recently, she was named a finalist for the MGH Department of Medicine Diversity and Inclusion Board Sanchez and Ferguson Research Faculty Award in 2021. 🌟

Teaching and Training:

Dr. Chika Anekwe’s commitment to education shines through her involvement in teaching and training programs. 📚 At SUNY Stony Brook Medical Center, she taught Foundations of Medical Practice to 1st and 2nd-year students, offering bi-weekly sessions over three semesters. Transitioning to HMS, she conducted clinical sessions on Metabolism, Nutrition, and Lifestyle Medicine for 3rd and 4th-year students. 🍏 In 2021, she engaged 1st-year HMS students in discussions on Health Policy during bi-weekly sessions. Her dedication continued with the creation of Advanced Integrated Science Course (AISC) sessions focusing on Nutrition, Obesity, and Equity for 3rd-year HMS students in 2023. 🏥

Research Focus:

Dr. Chika Anekwe’s research focuses primarily on the multifaceted aspects of obesity, spanning socioeconomics, pharmacotherapy, and healthcare delivery. 📊 Her work delves into understanding the socioeconomic factors influencing obesity prevalence and management, as well as exploring pharmacotherapeutic options and their effects on metabolic health. Additionally, she investigates the impact of bariatric surgery on diabetes management and compliance. Through her diverse studies, Dr. Anekwe contributes significantly to advancing our understanding of obesity-related conditions and their management, aiming to improve healthcare outcomes and quality of life for individuals affected by obesity. 🏥

Publication Top Notes:
  1. Socioeconomics of obesity📊 Published in Current obesity reports in 2020, cited by 102.
  2. Weight regulation in menopause🩸 Published in Menopause (New York, NY) in 2021, cited by 24.
  3. Ketogenic diet-induced elevated cholesterol, elevated liver enzymes and potential non-alcoholic fatty liver disease🥩 Published in Cureus in 2020, cited by 24.
  4. The role of bariatric surgery on diabetes and diabetic care compliance🩹 Published in Current diabetes reports in 2019, cited by 13.
  5. Pleural pressure targeted positive airway pressure improves cardiopulmonary function in spontaneously breathing patients with obesity🫁 Published in Chest in 2021, cited by 12.
  6. Pharmacotherapeutic options for weight regain after bariatric surgery💊 Published in Current Treatment Options in Gastroenterology in 2021, cited by 8.
  7. A Women’s health perspective on managing obesity🚺 Published in Progress in Cardiovascular Diseases in 2023, cited by 3.
  8. Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity‐related conditions: A review📑 Published in Annals of the New York Academy of Sciences, year of publication unspecified.
  9. Epidemiology of obesity among people with HIV🩺 Published in Current Opinion in HIV and AIDS in 2024, year of publication unspecified.
  10. Role of Reimbursement in the Delivery of Treatment for Obesity in Adults and Children💰 Published in Handbook of Obesity-Volume 2 in 2023, year of publication unspecified.